Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer

This study aimed to investigate the value of dynamic changes of midkine (MK) to monitor post-surgical patients with papillary thyroid cancer (PTC) who were managed with (131)I therapies. MK concentration at initial (131)I ablation therapy (MK1) as well as 10 to 12 months thereafter (MK2) was evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Zhang, Chunmei, Meng, Zhaowei, Xu, Ke, He, Xianghui, Yu, Yang, Jia, Qiang, Li, Xue, Liu, Xiangxiang, Wang, Xiaoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133610/
https://www.ncbi.nlm.nih.gov/pubmed/30200153
http://dx.doi.org/10.1097/MD.0000000000012242

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133610/
https://www.ncbi.nlm.nih.gov/pubmed/30200153
http://dx.doi.org/10.1097/MD.0000000000012242

Ejemplares similares